Search Results for

S1931

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial (PROBE)

Continue Reading »

---

MK-6482-011

A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma

Continue Reading »

---

A031702

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Continue Reading »

---

A031704

Nivolumab and Ipilimumab Followed by Nivolumab Versus Cabozantinib and Nivolumab in Treating Patients With Metastatic Untreated Renal Cell Cancer

Continue Reading »

---

Search Again

• All Trial Categories Anal  (2) Bladder/Urinary Tract Cancer  (7)    Metastatic  (3)    Neoadjuvant  (4) Brain  (7)    Glioblastoma Multiforme (GBM)  (3)    Other Brain Tumors  (3) Breast  (17)    1st Line Metastatic Breast, Metastasis at Presentation or Progression of earlier Disease  (4)    2nd Line Metastatic Breast, Progressive Disease Following 1st Line Therapy  (1)    Breast Cancer Adjuvant  (3)    DCIS/LCIS  (1) Cancer Control/Symptom Management  (19) Colorectal Cancer  (8)    Metastatic  (3)    Rectal Neoadjuvant  (1) Esophageal Cancer  (2) Gall Bladder/ Biliary Tract Cancer  (2) Gastric Cancer  (1)    Metastaic Gastric Cancer  (1) Head/Neck Cancer  (5)    Resectable Oral Cavity Cancer  (1)       Primary Chemoradiation Regimens  (1) Leukemia  (6)    Acute Myeloid Leukemia (AML)  (1)    B-Cell Chromic Lymphocytic Leukemia (CLL) / Small Ly  (3) Liver/Hepatocellular Carcinoma  (1) Lung Cancer  (26)    Non-Small Cell Lung Cancer  (18)       1st Line Metastatic, Stage3b with Maligned Effusion or Stage 4 Disease at Presentation or Recurrence  (5)       2nd Line Metastatic, Stage 4 Patients with Progressive Disease  (3)       Adjuvant Treatment for Resected NSCLC  (3)    Small Cell Lung Cancer  (8)       Extensive Stage SCLC  (5) Lymphoma  (5)    Non-Hodgkin’s Lymphoma  (2)       Follicular Lymphoma  (1)          Relapsed/Refractory  (1) MATCH Trial  (1) MDS  (3) Melanoma  (5)    Metastatic  (2) Merkel Cell Carcinoma  (1) Multiple Myeloma  (2) Pancreatic  (4)    Metastatic Disease  (2) Prostate  (10) Renal Cell/Kidney Cancer  (4)    Locally Advanced/Metastatic  (4) Sarcoma  (2) Small Bowel  (1)